Huran Tablet 150 mg (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
(Co., Ltd.) Hubist Pharmaceutical
MFDS item code 201404136 · Approved 2014.09.04
This product's status changed to Expired on 2024.09.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
This drug is used for the treatment of gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps prevent Mendelson's syndrome during preoperative anesthesia and manages ulcers post-surgery. It is also indicated for ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is effective in improving various gastric mucosal lesions, including acute exacerbations of acute and chronic gastritis, upper gastrointestinal bleeding, and more. This drug can also be used to relieve heartburn and acid regurgitation due to excessive gastric acid. Overall, it is a very useful drug for improving gastric acid-related diseases and gastric mucosal damage.
Administer ranitidine 150 mg orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer this drug 150 mg orally twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The same dosage applies when this drug is used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; for conditions caused by nonsteroidal anti-inflammatory drugs, healing usually occurs within 8 weeks, although healing time may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer this drug 150 mg twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg four times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with this drug at 150 mg three times daily, and increase the dose as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration of this drug at 150 mg twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Administer this drug 150 mg once daily at bedtime. 7) Excess stomach acid, heartburn, acid regurgitation: For patients aged 12 years or older, administer this drug 75 mg orally twice daily (for oral solution only). For patients with severe renal impairment and a creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
8 〜 18 years: 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily.
This drug should not be used in patients who are allergic to specific components or have a history of acute porphyria. In patients with impaired kidney function, the concentration of this drug may increase, requiring dosage adjustment, and caution is also needed in patients with liver dysfunction or the elderly. Care should be exercised when taking this drug with non-steroidal anti-inflammatory drugs, and patients with gastric ulcers or those over middle age who newly present with dyspeptic symptoms should use the drug only after excluding the possibility of gastric cancer. This drug may cause allergic reactions such as urticaria, rash, and difficulty breathing, so if any unusual symptoms occur, discontinue use immediately. Blood abnormalities, liver dysfunction, arrhythmias, gastrointestinal issues, neurological symptoms, and other various side effects may occur rarely; if symptoms arise, consult a medical professional. If dizziness or drowsiness occurs during use, it is advisable to avoid driving or operating hazardous machinery. There may be interactions with other drugs, so if you are taking any medications, be sure to inform your healthcare provider, especially when taking anticoagulants, as frequent blood tests are necessary. Pregnant or breastfeeding women should exercise caution while using this drug as it can be transmitted through the placenta and breast milk. Safety in children has not been sufficiently established, so caution is needed. In case of overdose, specific toxic symptoms are rare, but emergency treatment such as vomiting or gastric lavage may be needed. This drug should be kept out of the reach of children and not transferred to another container for safety. Additionally, long-term use may affect eye health, so regular eye examinations are recommended.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light, so it should be stored in a container that prevents light exposure. Furthermore, it is important to store it at a cool room temperature, specifically between 1 degree and 30 degrees Celsius, to maintain its effectiveness.
Off-white to light yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
(Co., Ltd.) Hubist Pharmaceutical
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.